Who owns Adaptimmune Therapeutics?

Top investors of Adaptimmune Therapeutics stock

Who bought or sold Adaptimmune Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
Matrix Capital Management Company 38.97M $390.13M 13% Jun 2020
NEA Management Company 17.08M $171.00M 0% Jun 2020
RA Capital Management 13.05M $130.66M 4% Jun 2020
venBio Select Advisor 10.20M $102.10M 100% Jun 2020
Capital World Investors 8.00M $80.11M 0% Jun 2020
Baker Bros. Advisors 6.68M $66.82M 81% Jun 2020
Baillie Gifford & Co 5.29M $52.95M 21% Jun 2020
Citadel Advisors 3.42M $34.20M 63% Jun 2020
Rtw Investments 2.60M $26.03M 100% Jun 2020
FMR 2.52M $25.26M 60% Jun 2020
Farallon Capital Management 2.50M $25.02M 100% Jun 2020
Rock Springs Capital Management 1.99M $19.89M 66% Jun 2020
Victory Capital Management 1.92M $19.18M 100% Jun 2020
Millennium Management 1.79M $17.89M 23% Jun 2020
Renaissance Technologies 1.71M $17.07M -3% Jun 2020
Avidity Partners Management 1.44M $14.39M 100% Jun 2020
Capital Research and Management Company - Division 3 1.32M $13.22M 0% Jun 2020
Longwood Capital Partners 1.17M $11.66M 100% Jun 2020
VR Adviser 781.94k $7.83M 100% Jun 2020
Lord, Abbett & Co 507.52k $5.08M 100% Jun 2020
Jpmorgan Chase & Co 500.23k $5.01M 417% Jun 2020
Endurant Capital Management 483.10k $4.84M 202% Jun 2020
Susquehanna International 445.10k $4.46M 100% Jun 2020
Rathbones Brothers 442.92k $4.43M 11% Jun 2020
Goldman Sachs Group 438.67k $4.39M 100% Jun 2020
Marshall Wace North America 437.89k $4.38M 100% Jun 2020
Perceptive Advisors 400.00k $4.00M 100% Jun 2020
Marshall Wace 376.34k $3.77M 100% Jun 2020
J. Goldman & Co 311.15k $3.12M 100% Jun 2020
Suvretta Capital Management 268.90k $2.69M 100% Jun 2020
CalPERS 235.71k $2.36M 673% Jun 2020
Maven Securities 225.00k $2.25M 100% Jun 2020
ALPS Advisors 205.45k $2.06M 100% Jun 2020
State Street Corporation 172.23k $1.72M 100% Jun 2020
Pinz Capital Management 158.40k $1.59M 100% Jun 2020
Vident Investment Advisory 140.53k $1.41M 100% Jun 2020
WS Management 121.54k $1.22M -15% Jun 2020
Caption Management 99.20k $992.00k 100% Jun 2020
Walleye Trading Advisors 95.10k $952.00k 100% Jun 2020
Athanor Capital 92.27k $924.00k 100% Jun 2020
Susquehanna Fundamental Investments 64.20k $643.00k 100% Jun 2020
Alyeska Investment Group 62.57k $626.00k 100% Jun 2020
Geode Capital Management 60.95k $610.00k 19% Jun 2020
Jane Street 50.60k $506.00k 100% Jun 2020
Ensign Peak Advisors 45.45k $455.00k 100% Jun 2020
Cutler 44.70k $447.00k 658% Jun 2020
Leap Investments 40.20k $402.00k 100% Jun 2020
Morgan Stanley 37.92k $380.00k 32% Jun 2020
Man Group 37.16k $372.00k 10% Jun 2020
Virtus ETF Advisers 35.24k $353.00k 100% Jun 2020
Group One Trading 28.62k $287.00k 100% Jun 2020
Commonwealth Equity Services 28.50k $285.00k 100% Jun 2020
Aperio Group 23.33k $234.00k 25% Jun 2020
HAP Trading 21.30k $23.00k 100% Jun 2020
K.J. Harrison & Partners 20.00k $200.00k 100% Jun 2020
Virtu Financial 19.84k $199.00k 100% Jun 2020
Cubist Systematic Strategies 19.74k $198.00k 100% Jun 2020
Stifel Financial 15.43k $154.00k 100% Jun 2020
PanAgora Asset Management 13.86k $139.00k -25% Jun 2020
Raymond James & Associates 10.40k $104.00k -50% Jun 2020
Barclays 7.40k $74.00k 0% Jun 2020
KBC Group NV 5.90k $59.00k 0% Jun 2020
Lindbrook Capital 4.06k $41.00k 333% Jun 2020
Bank of America Corporation 2.19k $22.00k -5% Jun 2020
Rockefeller Capital Management 2.00k $20.00k 0% Jun 2020
Wells Fargo & Company 1.95k $19.51k 678% Jun 2020
Simplex Trading 1.71k $16 -46% Jun 2020
Us Bancorp 1.36k $13.72k -31% Jun 2020
Royal Bank of Canada 1.00k $10.00k -49% Jun 2020
Citigroup 993 $10.00k -54% Jun 2020
Parallel Advisors 715 $7.00k -34% Jun 2020
Hoover Financial Advisors 655 $7.00k 100% Jun 2020
Sowell Financial Services 595 $6.00k 100% Jun 2020
Creative Financial Designs 400 $4.00k 100% Jun 2020
Signature 373 $4.00k 100% Jun 2020
Private Advisor 300 $3.00k 100% Jun 2020
Quadrant Capital 131 $1.00k 100% Jun 2020
Exane Derivatives 121 $1.21k 0% Jun 2020
UBS Group 70 $999 -99% Jun 2020

Who sold out of Adaptimmune Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
OrbiMed Advisors Mar 2020 2.53M $6.87M
Polygon Management Mar 2020 750.00k $2.04M
GSA Capital Partners Mar 2020 19.22k $52.00k
Invesco Mar 2020 17.45k $47.00k
Squarepoint Ops Mar 2020 12.55k $34.00k
Tower Research Capital Mar 2020 9.59k $26.00k
Wealthcare Advisory Partners Mar 2020 3.05k $8.00k
NEXT Financial Mar 2020 475 $1.00k
Advisory Services Network Mar 2020 100 $0

Funds that own Adaptimmune Therapeutics also own: